India's COVID-19 vaccine export ban excludes Bangladesh: Minister

India's drug regulator Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news